Netty has over 20 years’ experience as a specialist oncology pharmacist working in both government and private organisations within the UK. She is currently Principal Pharmacist – Cancer Services, for Lewisham and Greenwich NHS Trust. Netty is currently President of The International Society of Oncology Pharmacy Practitioners (ISOPP) and co-chair of the UK SACT Board. Netty has previously held various leadership positions within the British Oncology Pharmacy Association (BOPA) and has independently led several National and International Projects. Netty was announced a Fellow of the Royal Pharmaceutical Society in 2022 and a Fellow of BOPA in 2023.
Netty is passionate about improving cancer care globally and improving safety for patients and staff through the use of digital media. Netty also has a keen interest in education and training and uses her strengths to support all pharmacy staff in all sectors and countries to improve access to learning globally.

Chin Hua Kuan, PharmD, BCOP, is a board-certified oncology pharmacist, serving as a clinical pharmacist in the department of Haematology in Singapore General Hospital (SGH). Dr. Kuan underwent his undergraduate training at China Medical University in Taiwan and postgraduate training at National University of Singapore. He also completed National Pharmacy Residency Year 1 Programme in Singapore. His practice involves malignant haematology, bone marrow transplantation and cellular therapy. 

Jenny Rogers is an oncology research pharmacist working across real-world thoracic cancer research and pharmacy-led clinical and health services research. Her work includes support for a multisite thoracic cancer database, with involvement in site engagement, ethics and governance, data management, and quantitative analysis.

Associate Professor Safeera Hussainy is a Senior Pharmacist, and her career has spanned working across academic, community pharmacy and hospital sectors. She is currently Senior Pharmacy Research Manager at Peter MacCallum Cancer Centre ("Peter Mac"), responsible for leading the Pharmacy Department’s research strategy. Under her leadership, the department has achieved its 5 year shared vision and amplified its research program outputs. Safeera is also Adjunct Associate Professor at Monash University, Honorary Principal Fellow at University of Melbourne, and Chief Investigator on three government-funded multidisciplinary trials where she contributes expertise in health services, mixed methods and education innovation research. A recognised leader and passionate advocate in sexual and reproductive health, Safeera's work has had shaped policy and practice and has been the subject of media commentary e.g. The Project TV, Marie Claire, ABC News, The Guardian, The Oncology Podcast. Her research has spurred national clinical guideline change for the supply of emergency contraception, and her training of the pharmacy profession has won LearnX awards as well as improved adherence to guideline recommendations and equity in access to contraception by women. At Peter Mac, Safeera is leading the co-design of a sexuality clinic to improve sexual health outcomes for patients, reduce distress and improve quality of life, and increase staff knowledge and confidence in providing sexual health care. Her bold leadership in this fresh new space recently won her a prestigious Peter Mac 2026 Lea Medal. Alongside this work, Safeera spearheaded the development and implementation of an innovative accredited continuing education program in oncology pharmacogenomics where she trained 15 hospital pharmacists from metropolitan and rural/remote settings, and has championed national research on barriers/enablers to research to accelerate pharmacist-clinician researcher pathways. Safeera has co-authored 59 peer-reviewed publications and > 90 conference presentations, has been invited speaker at > 30 conferences and other events, and received $11.45 million in competitive national research funding.

Shaun O'Connor is the Senior Cancer Services Pharmacist and St Vincent's Public Hospital Melbourne and has worked for the Department of Health, Victoria. He is a Helen McKinnon award recipient, Standards Taskforce Vice-chair of the International Society of Oncology Pharmacy Practitioners and chair of the Advanced Pharmacy Australia Oncology/Haematology Leadership Committee. He was responsible for developing the VicTAG Chemotherapy Audit Toolkit.

"Dr. Supat Subongkot is an Associate Professor in the Clinical Pharmacy Division at Khon Kaen University, Thailand. Holding a Pharm.D. and specialized training, including a Fellowship from Rush University Medical Center, Chicago, IL, he is a certified oncology pharmacist (BCOP, BCPS).

Dr. Subongkot is a passionate leader focused on oncology pharmacy and education, spearheading regional collaboration through organizations such as ACCP, APOPC, and ISOPP. He is dedicated to advancing clinical research, patient care, and equipping future pharmacists with cutting-edge knowledge, notably recognized for his innovative classroom action research awards."

Yin Ting Cheung is an Associate Professor at the School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong. She received her training in cancer pharmacoepidemiology at the National University of Singapore and St. Jude Children’s Research Hospital in Memphis, USA. Her research focuses on supportive care and survivorship among patients with cancer. She also conducts population-based studies and applies implementation science approaches to assess the effectiveness of integrative medicines and integrative oncology programs, particularly for children, adolescents, and young adults with life-limiting conditions. She serves as a member of the Clinical Practice Committee of the Society for Integrative Oncology (SIO).

Emma has been an oncology pharmacist for over 25 years, culminating in a Consultant Pharmacist post at the Royal Marsden Hospital.  During her career she has been Chair of the British Oncology Pharmacy Association, and Chair of the ISOPP Biosimilars Taskforce. Now retired from work, Emma is still playing and active role in ISOPP and is currently chair of the Standards Taskforce

Emma has been an oncology pharmacist for over 25 years, culminating in a Consultant Pharmacist post at the Royal Marsden Hospital.  During her career she has been Chair of the British Oncology Pharmacy Association, and Chair of the ISOPP Biosimilars Taskforce. Now retired from work, Emma is still playing and active role in ISOPP and is currently chair of the Standards Taskforce

Harbans worked as a pharmacist for 37 years, specialising in aseptic dispensing and incology in the University Malaya Medical Centre before retiring in 2017. She still works part-time as a community pharmacist. Harbans was the President of ISOPP (International Society of Oncology Pharmacy Practitioners) 2016 - 2018, and is still actively involved in ISOPP and is heading the Safe Handling Task Force.

Dr. Gavin Orangi is an Oncology Pharmacy Specialist, Health Systems manager and a member of the Oncology Pharmacists Society of Kenya(OPSoK). He serves as the County Antimicrobial Stewardship Coordinator across 244 facilities in Makueni, Kenya and a member of Kenya’s National Antimicrobial Stewardship Technical Working Group. Dr. Orangi also coordinates county oncology services, overseeing cancer screening, treatment, and palliative care programs. His work integrates health systems strengthening, stewardship science and oncology pharmacy. He is also actively engaged in policy development, surveillance of antimicrobial use and resistance, and implementation research aimed at optimizing therapeutic outcomes in resource-limited settings.

Dr Ebenezer Wiafe is a lecturer at the Department of Pharmacy Practice, School of Pharmacy, University of Health and Allied Sciences, Ghana and a postdoctoral research fellow at the Centre of Excellence for Pharmacovigilance in Southern Africa, School of Public Health, University of the Western Cape, South Africa.

Ebenezer is a registered pharmacist in Ghana, holding a Doctor of Pharmacy, Master of Pharmacy, and Doctor of Philosophy (Pharmacy Practice) degrees. 

He is a qualified person for pharmacovigilance (QPPV) and currently specialising in clinical oncology pharmacy with the Ghana College of Pharmacists and the West African Postgraduate College of Pharmacists.

Dr Muhammad Tahir (PhD) is a leading practitioner pharmacist and hospital management expert. He spearheaded impactful pharmacy and hospital projects at the Shaukat Khanum Cancer Hospital (SKMCH&RC) in Pakistan. He is an M.Phil. and PhD in Pharmacy Practice and earned Exec. MBA degree from Pakistan. He got training in clinical pharmacy from Whipps Cross University Hospital, London, UK and completed the Healthcare Leadership program from Utrecht University, Netherlands. He has numerous publications in respected pharmacy and medical journals. Dr Tahir's leadership experience spans over 15 years as Assoc. Director of Pharmacy and currently serves as Chief Operating Officer at SKMCH&RC, Lahore. 

Calum Polwart has been working in oncology pharmacy for more than 25 years. He has undertaken a number of roles within the North of England to provide world class oncology pharmacy services. He is a non-medical prescriber working in a variety of solid tumours including Breast and GI cancers. He is accredited with the Royal Pharmaceutical Society as a Consultant Pharmacist. 

A self-confessed ‘geek’ he spends more time working with data in a week than “normal” people should in a lifetime! Despite that he still hasn’t been awarded a nobel prize ;-). Polwart has worked at a national level to implement the NHS England National Dose Standardisation Project to find a single national solution for dose banding in England, and continued to support their program of dose banding and product standardisation. Carrying a reputation for having an opinion on most things, he is likely to challenge convention and push for "pragmatic common sense" in his words.

Dr Ebenezer Wiafe is a lecturer at the Department of Pharmacy Practice, School of Pharmacy, University of Health and Allied Sciences, Ghana and a postdoctoral research fellow at the Centre of Excellence for Pharmacovigilance in Southern Africa, School of Public Health, University of the Western Cape, South Africa.

Ebenezer is a registered pharmacist in Ghana, holding a Doctor of Pharmacy, Master of Pharmacy, and Doctor of Philosophy (Pharmacy Practice) degrees. 

He is a qualified person for pharmacovigilance (QPPV) and currently specialising in clinical oncology pharmacy with the Ghana College of Pharmacists and the West African Postgraduate College of Pharmacists.

Dr Muhammad Tahir (PhD) is a leading practitioner pharmacist and hospital management expert. He spearheaded impactful pharmacy and hospital projects at the Shaukat Khanum Cancer Hospital (SKMCH&RC) in Pakistan. He is an M.Phil. and PhD in Pharmacy Practice and earned Exec. MBA degree from Pakistan. He got training in clinical pharmacy from Whipps Cross University Hospital, London, UK and completed the Healthcare Leadership program from Utrecht University, Netherlands. He has numerous publications in respected pharmacy and medical journals. Dr Tahir's leadership experience spans over 15 years as Assoc. Director of Pharmacy and currently serves as Chief Operating Officer at SKMCH&RC, Lahore. 

Dr Muhammad Tahir (PhD) is a leading practitioner pharmacist and hospital management expert. He spearheaded impactful pharmacy and hospital projects at the Shaukat Khanum Cancer Hospital (SKMCH&RC) in Pakistan. He is an M.Phil. and PhD in Pharmacy Practice and earned Exec. MBA degree from Pakistan. He got training in clinical pharmacy from Whipps Cross University Hospital, London, UK and completed the Healthcare Leadership program from Utrecht University, Netherlands. He has numerous publications in respected pharmacy and medical journals. Dr Tahir's leadership experience spans over 15 years as Assoc. Director of Pharmacy and currently serves as Chief Operating Officer at SKMCH&RC, Lahore. 

Nick is a Consultant Haematology Pharmacist at University Hospitals Birmingham NHS Trust and an Honorary Assistant Professor in the School of Pharmacy, University of Birmingham.  

He is a Fellow of the British Oncology Pharmacy Association and The Royal Pharmaceutical Society of Great Britain and is the current Chair of the ISOPP Research Committee.

Nthongase Makamo is a pharmacist and researcher specializing in pediatric oncology in resource-limited settings. Her work focuses on optimizing medication use, improving treatment adherence, and advancing clinical research to enhance outcomes for children with cancer. She has a particular interest in pharmacokinetics, pharmacometrics, and the impact of malnutrition on cancer therapy, and is committed to promoting equitable access to quality cancer care.

Netty has over 20 years’ experience as a specialist oncology pharmacist working in both government and private organisations within the UK. She is currently Principal Pharmacist – Cancer Services, for Lewisham and Greenwich NHS Trust. Netty is currently President of The International Society of Oncology Pharmacy Practitioners (ISOPP) and co-chair of the UK SACT Board. Netty has previously held various leadership positions within the British Oncology Pharmacy Association (BOPA) and has independently led several National and International Projects. Netty was announced a Fellow of the Royal Pharmaceutical Society in 2022 and a Fellow of BOPA in 2023.
Netty is passionate about improving cancer care globally and improving safety for patients and staff through the use of digital media. Netty also has a keen interest in education and training and uses her strengths to support all pharmacy staff in all sectors and countries to improve access to learning globally.

María Espinosa Bosch, PharmD, PhD.

Hospital Pharmacist at Hospital Regional Universitario de Málaga.

Member of the GEDEFO–SEFH coordinating group.

Hospital Pharmacy Residency Tutor.

Honorary Associate Professor in the Department of Pharmacology, Faculty of Medicine, University of Málaga.

A registered pharmacist with over 30 years’ experience of delivering patient focussed pharmaceutical care. A chief hospital pharmacist since 2005, 12 years of which have been spent managing the pharmacy service at the two largest cancer centres in the UK (The Christie, Manchester; The Royal Marsden, London). An innovative leader who inspires the multi-disciplinary teams he leads. In recent years the initiatives that he has led have led to practice changes on a national level with the introduction of national dose banding for chemotherapy along with supporting the full adoption of Ready To use Chemotherapy in the UK.

Nick is a Consultant Haematology Pharmacist at University Hospitals Birmingham NHS Trust and an Honorary Assistant Professor in the School of Pharmacy, University of Birmingham.  

He is a Fellow of the British Oncology Pharmacy Association and The Royal Pharmaceutical Society of Great Britain and is the current Chair of the ISOPP Research Committee.

Steve Williamson is NICE’s Associate Director for Managed Access, overseeing the Cancer Drugs Fund (CDF), the Innovative Medicines Fund (IMF), and the Early Value Assessment (EVA) of Healthtech. Steve’s team is responsible for all aspects of the development, planning, and delivery of Managed Access, collaborating closely with NHS England payer colleagues. As a member of the NICE Commercial, Managed Access, and Medicines Policy leadership team, Steve is a key opinion leader in NICE’s managed access, evidence generation, commercial activities, and national medicines policy. Steve is a recognised international speaker representing NICE and sharing best practices with global Health Technology Assessment (HTA) colleagues. Additionally, Steve participates in the World Health Authority’s Novel Medicines Platform, developing international standards for Managed Entry Agreements to support market access for new medicines.

Steve is a pharmacist with a background in oncology and commissioning, along with extensive experience in HTA implementation of cancer medicines from a systems perspective. Before joining NICE, he served as NHS England’s National Lead Cancer Pharmacist for five years, following his position as a Consultant Cancer Pharmacist in Northeast England, where Steve was the lead clinician for Northumbria Trust's chemotherapy services. Steve is a past chair of the British Oncology Pharmacy Association, where he authored many of their guidelines and national standards. He teaches on the Oncology MSc degree course at Newcastle University and has published and conducted research on various topics, including cancer medicines, chemotherapy service delivery, real-world evidence, and the HTA process.  

Martin is an experienced Pharmacist, having worked in both hospital and industry settings. He has a particular focus on Aseptic Compounding of Medicinal Products for use in Haematology/Oncology, as TPN solutions and in Critical Care. More recently he has been working on projects supporting the implementation of information systems in Hospital Pharmacy Departments, including robotic compounding.

Nick is a Consultant Haematology Pharmacist at University Hospitals Birmingham NHS Trust and an Honorary Assistant Professor in the School of Pharmacy, University of Birmingham.  

He is a Fellow of the British Oncology Pharmacy Association and The Royal Pharmaceutical Society of Great Britain and is the current Chair of the ISOPP Research Committee.

Maxime Annereau is a hospital pharmacist, a hospital practitioner at Gustave Roussy cancer centre, and hold a PhD. In addition to his professional commitments, he has cultivated an interest in the personalisation of cancer treatment. In this regard, he has collaborated with the INSERM 1279 team to develop a prognostic score for colon cancer. Concurrently, he has sought to address the paucity of paediatric and adult formulations. In pursuit of this objective, he collaborated with paediatric teams to develop an oral formulation of temozolomide, initially at the hospital and subsequently adopted by the pharmaceutical industry. This work facilitated the establishment of a temporary use programme for dordaviprone in Europe, which was proposed by the Gustave Roussy pharmacy department in conjunction with the French Medicines Agency. The programme was initiated in 2021 and has since treated more than 350 patients. This success has led to the renewal of the programme, making Gustave Roussy the only institution to have a bromodomain inhibitor for the treatment of NUT carcinomas. In order to maintain the delivery of the most advanced treatments from the hospital, he is a fonding member for pharma3DPI, a scientific society to promote utilization of 3D printing technology for patient care. Consequently, a translational platform rooted in pharmaceutical science is currently being developed to address unmet needs within the pharmaceutical industry and facilitate the execution of clinical trials, in addition to the implementation of rapid real-life treatment approaches stemming from the conceptual frameworks of the Gustave Roussy research teams

Margaret Gye is an Advanced Oncology Pharmacist and Independent Prescriber at Mount Vernon Cancer Centre, specialising in systemic anti-cancer therapy (SACT) and electronic prescribing governance. Working across a multi-site consortium, she leads the management and optimisation of the SACT electronic prescribing system, with a particular interest in digitisation of oncology processes. Alongside her digital leadership role, Margaret delivers pharmacist-led oncology clinics and manages complex immunotherapy and targeted therapy pathways. She is also committed to professional wellbeing and has embedded clinical supervision within the oncology pharmacy services.

Wendy Ng is the Deputy Head of Pharmacy and Cancer Lead Pharmacist at Mount Vernon Cancer Centre, with 20 years of experience in oncology pharmacy across the NHS and private sectors. An Independent Prescriber with an MBA and currently pursuing a MSc in Healthcare Leadership studies, Wendy remains focused on finding practical ways to improve patient-centred care.

She helped to establish Non-Medical Prescribing Pharmacist clinics and develop a self-administration subcutaneous SACT model—an initiative she was proud to see shortlisted for a 2024 HSJ Award. Continuing her work to better support cancer patients throughout their treatment, Wendy is currently focused on integrating ePROMs and expanding clinical screening roles for pharmacy technicians.

Bastiaan Buijtenhuijs is Head of Product and Lead Oncology Pharmacist at iQ HealthTech, where he oversees the development of iQemo, a leading systemic anti-cancer therapy (SACT) prescribing system used across the UK and internationally. In this role, he bridges clinical oncology pharmacy needs with digital innovation, ensuring that user requirements are effectively translated into product functionality.

Bastiaan completed his MSc through the NHS Digital Academy (Cohort 3), focusing his dissertation on implementing AI-driven clinical decision-support systems in oncology pharmacy. He has also undertaken the NHS Digital Academy leadership programme, equipping him with strategic insight into digital transformation in healthcare. Bastiaan is working towards his PhD in Applied Artificial Intelligence at University College London.

His research interests include the application of AI in oncology pharmacy, clinical decision support and digital health innovation. He co-chairs the British Oncology Pharmacy Association (BOPA) Artificial Intelligence Specialist Advisory Group and regularly contributes to webinars and educational events on AI in pharmacy practice.

Bastiaan is an active presenter and advocate for digital health, with recent talks including BOPA’s 2025 webinar on administrative efficiency in oncology pharmacy.

Priv.-Doz. Dr. Claudia Langebrake is head of research and teaching in the hospital pharmacy and clinical pharmacist at the clinic for stem cell transplantation at the University Medical Center Hamburg-Eppendorf. Her particular scientific inter-ests include drug therapy safety in hospitals, pharmaceutical interventions and clinical pharmacokinetics. In addition to her commitment to the German Association of Hospital Pharmacists (ADKA) as the Chairwoman of the Scientific Commit-tee and the Committee for Pharmaceutical Interventions, she is active in various national and international professional societies and committees, including the Pharmacists Committee of the EBMT and the Pharmacists Working Group of the GoCART coalition.

Nick is a Consultant Haematology Pharmacist at University Hospitals Birmingham NHS Trust and an Honorary Assistant Professor in the School of Pharmacy, University of Birmingham.  

He is a Fellow of the British Oncology Pharmacy Association and The Royal Pharmaceutical Society of Great Britain and is the current Chair of the ISOPP Research Committee.

Dr Kieran Dalton is a Senior Lecturer in Clinical Pharmacy in University College Cork, Ireland who has practised as a pharmacist in hospital pharmacy, community pharmacy, and long-term care settings. Stemming from this clinical work and his PhD on medication optimisation in older adults, Kieran has published a wealth of research in the field of deprescribing, particularly regarding older adults with polypharmacy. This has included conducting pharmacist-led interventions across a range of healthcare settings which have demonstrated several positive impacts, including enhanced medication appropriateness, improved patient-reported outcomes, and meaningful reductions in medication costs. More information can be found here: research.ucc.ie/en/persons/kieran-dalton/

Bastiaan Buijtenhuijs is Head of Product and Lead Oncology Pharmacist at iQ HealthTech, where he oversees the development of iQemo, a leading systemic anti-cancer therapy (SACT) prescribing system used across the UK and internationally. In this role, he bridges clinical oncology pharmacy needs with digital innovation, ensuring that user requirements are effectively translated into product functionality.

Bastiaan completed his MSc through the NHS Digital Academy (Cohort 3), focusing his dissertation on implementing AI-driven clinical decision-support systems in oncology pharmacy. He has also undertaken the NHS Digital Academy leadership programme, equipping him with strategic insight into digital transformation in healthcare. Bastiaan is working towards his PhD in Applied Artificial Intelligence at University College London.

His research interests include the application of AI in oncology pharmacy, clinical decision support and digital health innovation. He co-chairs the British Oncology Pharmacy Association (BOPA) Artificial Intelligence Specialist Advisory Group and regularly contributes to webinars and educational events on AI in pharmacy practice.

Bastiaan is an active presenter and advocate for digital health, with recent talks including BOPA’s 2025 webinar on administrative efficiency in oncology pharmacy.

Frances is a pharmacy clinical practice leader at the new Arthur Child Comprehensive Cancer Centre in Calgary, Alberta, Canada. She enjoys working with patients, physicians and nurses in the ambulatory neuro oncology clinics at the Arthur Child. Frances is also the Year 1 residency coordinator for the Cancer program in Alberta and the lead for the ISOPP Environmental Sustainability Task Force.

Netty has over 20 years’ experience as a specialist oncology pharmacist working in both government and private organisations within the UK. She is currently Principal Pharmacist – Cancer Services, for Lewisham and Greenwich NHS Trust. Netty is currently President of The International Society of Oncology Pharmacy Practitioners (ISOPP) and co-chair of the UK SACT Board. Netty has previously held various leadership positions within the British Oncology Pharmacy Association (BOPA) and has independently led several National and International Projects. Netty was announced a Fellow of the Royal Pharmaceutical Society in 2022 and a Fellow of BOPA in 2023.
Netty is passionate about improving cancer care globally and improving safety for patients and staff through the use of digital media. Netty also has a keen interest in education and training and uses her strengths to support all pharmacy staff in all sectors and countries to improve access to learning globally.

Colleen Timlin is the Associate Director of Ambulatory Oncology Practices at the Hospital of the University of Pennsylvania in Philadelphia, PA, USA.   She was an Oncology Pharmacy Specialist in inpatient and ambulatory hematology as well as pharmacy manager before moving into her current role.    Colleen is an active member of a number of national organizations and has mentored many oncology practitioners as the PGY2 Residency Program Director at Penn.   

Khushminder Dhillon is a Pharmacy Educator with BC Cancer, where she supports oncology pharmacy practice across British Columbia as part of the Community Oncology Network (CON) Pharmacy Educators team. In this role, she facilitates professional development for pharmacists, pharmacy technicians, and pharmacy assistants, while developing key educational resources and training programs that help standardize and strengthen oncology pharmacy care throughout BC. With extensive experience in oncology practice and clinical education, Khushminder can translate complex oncology concepts into accessible and practical learning for diverse audiences. Her work includes delivering instructional sessions, providing expert consultation on drug information, and supporting clinical teaching across oncology sites. She is also known for her collaborative approach and her dedication to elevating pharmacy practice standards in cancer care. 

Justin Robert Arnall, PharmD, FCCP, BCOP, is a Board Certified Oncology Pharmacist and Residency Program Director for the PGY1 Pharmacy program in the setting of Ambulatory Clinics & Specialty Pharmacy at Atrium Health, Carolinas Medical Center/Specialty Pharmacy Service. He serves as Pharmacist Clinical Coordinator in Hematology within Atrium Health’s Specialty Pharmacy Service, and in this role supports the bleeding disorders and hematology service lines, rounds with a hematology consult team daily, and provide peripheral support for several hematology clinics. Dr. Arnall’s clinical and operational leadership spans non malignant hematology (hemophilia, TTP, ITP, complement mediated diseases), hematologic malignancies, bone marrow transplantation, anticoagulation stewardship, and specialty pharmacy models of care.  Dr. Arnall completed his PGY1 Pharmacy practice and PGY2 Oncology residencies at Wake Forest Baptist Medical Center and earned his PharmD from the UNC Eshelman School of Pharmacy.  

A registered pharmacist with over 30 years’ experience of delivering patient focussed pharmaceutical care. A chief hospital pharmacist since 2005, 12 years of which have been spent managing the pharmacy service at the two largest cancer centres in the UK (The Christie, Manchester; The Royal Marsden, London). An innovative leader who inspires the multi-disciplinary teams he leads. In recent years the initiatives that he has led have led to practice changes on a national level with the introduction of national dose banding for chemotherapy along with supporting the full adoption of Ready To use Chemotherapy in the UK.

Amy has worked within APTUK since 2018 where she has held roles including National Officer - Foundation Frameworks, Director of Education and Vice President.

Amy has worked in Pharmacy since 2005 in a variety of sectors, all of which led her to academia and her passion for developing and implementing pharmacy courses to support an inclusive and diverse workforce that aims to ensure the safety of medicines for patients and our society.

Having moved into an academic role in 2013, Amy now works at West Suffolk College, part of the Eastern Education group. Since 2019 Amy has led on the implementation of Science Manufacturing Technicians and Science Manufacturing Process operatives within technical services.

Pharmacist – Oncology Specialist (Albert Einstein Teaching and Research Institute) | Clinical Protocols Specialist at Oncoclínicas&Co Group | MBA in Healthcare Management, Innovation and Services (PUC-RS) | Healthcare Leadership (Stanford Center for Health Education) | Member of the Environmental Sustainability Task Force at the International Society of Oncology Pharmacy Practitioners (ISOPP)

Frances is a pharmacy clinical practice leader at the new Arthur Child Comprehensive Cancer Centre in Calgary, Alberta, Canada. She enjoys working with patients, physicians and nurses in the ambulatory neuro oncology clinics at the Arthur Child. Frances is also the Year 1 residency coordinator for the Cancer program in Alberta and the lead for the ISOPP Environmental Sustainability Task Force.

Pharmacist, with a master's in Pharmaceutical Sciences and a ScD in Collective Health. Research Fellowship with the Division of Clinical Pharmacology, Karolinska Institutet, Huddinge, Sweden. Consultant to the Brazilian MoH and to DIGEMID/MoH, Peru. Editorial Board Member and Associate Editor of scientific journals on Public Health and Council Member in scientific societies. Member of the WHO Expert Group on Essential Medicines. Research Fellow of the Brazilian Research and Development Council and Research Leader on Essential Medicines. At present Senior Professor at Oswaldo Cruz Foundation, Rio de Janeiro. Areas of interest: Medicines Policies, Drug Utilization Research, Pharmaceutical Services, Disasters and Bioethics.

Netty has over 20 years’ experience as a specialist oncology pharmacist working in both government and private organisations within the UK. She is currently Principal Pharmacist – Cancer Services, for Lewisham and Greenwich NHS Trust. Netty is currently President of The International Society of Oncology Pharmacy Practitioners (ISOPP) and co-chair of the UK SACT Board. Netty has previously held various leadership positions within the British Oncology Pharmacy Association (BOPA) and has independently led several National and International Projects. Netty was announced a Fellow of the Royal Pharmaceutical Society in 2022 and a Fellow of BOPA in 2023.
Netty is passionate about improving cancer care globally and improving safety for patients and staff through the use of digital media. Netty also has a keen interest in education and training and uses her strengths to support all pharmacy staff in all sectors and countries to improve access to learning globally.